Rodriguez v. ELI LILLY AND COMPANY

What this case is about

Consumers are suing Eli Lilly, a major pharmaceutical company, alleging that one or more of its pharmaceutical products caused personal injury or harm. The plaintiffs claim the drug or medical product was defective, unsafe, or unreasonably dangerous when used as intended or directed. The lawsuit suggests that Eli Lilly failed to adequately warn patients and healthcare providers about the risks associated with the product, or that the product itself was improperly designed or manufactured. The proposed class likely includes individuals who used the specific Eli Lilly pharmaceutical product at issue and suffered physical harm or adverse health effects as a result. The case is being heard in federal court based on diversity of citizenship between the parties.

What happens next

The case is in its earliest stage. The defendant has not yet responded. Class certification — the court's decision on whether the case can proceed as a class action — typically takes 12 to 24 months after filing. See our FAQ for how class actions work and what it means to be a class member.

Source: CourtListener docket entry. This summary was generated automatically from the public docket and has not been reviewed by an attorney. It may contain errors and may not reflect subsequent filings. Published by Access Law Group; responsible attorney Bogdan Enica, Esq..